Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR–T-cell responses against ALL
Open Access
- 10 March 2021
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 138 (2), 122-135
- https://doi.org/10.1182/blood.2020009309
Abstract
Chimeric antigen receptor (CAR)–T-cell therapeutic efficacy is associated with long-term T-cell persistence and acquisition of memory. Memory-subset formation requires T-cell factor 1 (TCF-1), a master transcription factor for which few regulators have been identified. Here, we demonstrate using an immune-competent mouse model of B-cell acute lymphoblastic leukemia (ALL; B-ALL) that Regnase-1 deficiency promotes TCF-1 expression to enhance CAR–T-cell expansion and memory-like cell formation. This leads to improved CAR-T–mediated tumor clearance, sustained remissions, and protection against secondary tumor challenge. Phenotypic, transcriptional, and epigenetic profiling identified increased tumor-dependent programming of Regnase-1–deficient CAR-T cells into TCF-1+ precursor exhausted T cells (TPEX) characterized by upregulation of both memory and exhaustion markers. Regnase-1 directly targets Tcf7 messenger RNA (mRNA); its deficiency augments TCF-1 expression leading to the formation of TPEX that support long-term CAR–T-cell persistence and function. Regnase-1 deficiency also reduces exhaustion and enhances the activity of TCF-1− CAR-T cells. We further validate these findings in human CAR-T cells, where Regnase-1 deficiency mediates enhanced tumor clearance in a xenograft B-ALL model. This is associated with increased persistence and expansion of a TCF-1+ CAR–T-cell population. Our findings demonstrate the pivotal roles of TPEX, Regnase-1, and TCF-1 in mediating CAR–T-cell persistence and recall responses, and identify Regnase-1 as a modulator of human CAR–T-cell longevity and potency that may be manipulated for improved therapeutic efficacy.Keywords
This publication has 56 references indexed in Scilit:
- Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15Blood, 2014
- The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cellsNature Immunology, 2014
- T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansionNature Immunology, 2013
- Malt1-Induced Cleavage of Regnase-1 in CD4+ Helper T Cells Regulates Immune ActivationCell, 2013
- Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktailsCancer Immunology, Immunotherapy, 2012
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced LeukemiaScience Translational Medicine, 2011
- Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1Immunity, 2010
- Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memoryProceedings of the National Academy of Sciences of the United States of America, 2010
- Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decayNature, 2009
- Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemiaLeukemia, 2004